Literature DB >> 17554374

Segmental uniparental disomy as a recurrent mechanism for homozygous CEBPA mutations in acute myeloid leukemia.

B J Wouters, M A Sanders, S Lugthart, W M C Geertsma-Kleinekoort, E van Drunen, H B Beverloo, B Löwenberg, P J M Valk, R Delwel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17554374     DOI： 10.1038/sj.leu.2404795

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  The role of different genetic subtypes of CEBPA mutated AML.

Authors:  A Fasan; C Haferlach; T Alpermann; S Jeromin; V Grossmann; C Eder; S Weissmann; F Dicker; A Kohlmann; S Schindela; W Kern; T Haferlach; S Schnittger
Journal:  Leukemia       Date:  2013-09-23       Impact factor: 11.528

2.  Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome.

Authors:  Bas J Wouters; Bob Löwenberg; Claudia A J Erpelinck-Verschueren; Wim L J van Putten; Peter J M Valk; Ruud Delwel
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

3.  New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.

Authors:  Ramon V Tiu; Lukasz P Gondek; Christine L O'Keefe; Jungwon Huh; Mikkael A Sekeres; Paul Elson; Michael A McDevitt; Xiao Fei Wang; Mark J Levis; Judith E Karp; Anjali S Advani; Jaroslaw P Maciejewski
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

4.  Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancer.

Authors:  Musaffe Tuna; Marcel Smid; Dakai Zhu; John W M Martens; Christopher I Amos
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 5.  A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.

Authors:  Bas J Wouters; Bob Löwenberg; Ruud Delwel
Journal:  Blood       Date:  2008-08-14       Impact factor: 22.113

6.  Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.

Authors:  Anna M Jankowska; Hadrian Szpurka; Ramon V Tiu; Hideki Makishima; Manuel Afable; Jungwon Huh; Christine L O'Keefe; Rebecca Ganetzky; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

7.  Utility of a Direct 16S rDNA PCR and Sequencing for Etiological Diagnosis of Infective Endocarditis.

Authors:  Min Sun Kim; Jeonghyun Chang; Mi Na Kim; Sang Ho Choi; Sung Ho Jung; Jae Won Lee; Heungsup Sung
Journal:  Ann Lab Med       Date:  2017-11       Impact factor: 3.464

8.  SNPExpress: integrated visualization of genome-wide genotypes, copy numbers and gene expression levels.

Authors:  Mathijs A Sanders; Roel G W Verhaak; Wendy M C Geertsma-Kleinekoort; Saman Abbas; Sebastiaan Horsman; Peter J van der Spek; Bob Löwenberg; Peter J M Valk
Journal:  BMC Genomics       Date:  2008-01-25       Impact factor: 3.969

9.  Variable outcome and methylation status according to CEBPA mutant type in double-mutated acute myeloid leukemia patients and the possible implications for treatment.

Authors:  Dima El-Sharkawi; Duncan Sproul; Christopher G Allen; Andrew Feber; Melissa Wright; Robert K Hills; David C Linch; Rosemary E Gale
Journal:  Haematologica       Date:  2017-10-12       Impact factor: 9.941
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.